Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Tuberculosis

Free Subscription Articles published in Eur J Clin Microbiol Infect Dis Retrieve available abstracts of 48 articles: HTML format

Single Articles

April 2021
1. NKWAGATSE T, Sturm AW
   Affinity of Mycobacterium tuberculosis strains for M059K microglial cells after migration through A549 alveolar epithelium.
   Eur J Clin Microbiol Infect Dis. 2021 Apr 9. pii: 10.1007/s10096-021-04226.
   PubMed     Abstract available
   
   
   
2. LIANG J, An H, Zhou J, Liu Y, et al
   Exploratory development of PCR-fluorescent probes in rapid detection of mutations associated with extensively drug-resistant tuberculosis.
   Eur J Clin Microbiol Infect Dis. 2021 Apr 1. pii: 10.1007/s10096-021-04236.
   PubMed     Abstract available
   
   
   November 2020
3. ZHENG H, Zhong F, Yu G, Shen Y, et al
   Comparison of the diagnostic efficacy of the CapitalBio Mycobacterium real-time polymerase chain reaction detection test and Xpert MTB/RIF in smear-negative pulmonary tuberculosis.
   Eur J Clin Microbiol Infect Dis. 2020 Nov 26. pii: 10.1007/s10096-020-04113.
   PubMed     Abstract available
   
   
   
4. CHEE CBE, Lim LKY, Ong RTH, Sng LH, et al
   Whole genome sequencing analysis of multidrug-resistant tuberculosis in Singapore, 2006-2018.
   Eur J Clin Microbiol Infect Dis. 2020 Nov 15. pii: 10.1007/s10096-020-04100.
   PubMed     Abstract available
   
   
   October 2020
5. KANG W, Du J, Yang S, Yu J, et al
   The prevalence and risks of major comorbidities among inpatients with pulmonary tuberculosis in China from a gender and age perspective: a large-scale multicenter observational study.
   Eur J Clin Microbiol Infect Dis. 2020 Oct 22. pii: 10.1007/s10096-020-04077.
   PubMed     Abstract available
   
   
   September 2020
6. LIU P, Wang Y, Hao S, Qin Y, et al
   Comparison of the CapitalBioMycobacterium RT-PCR detection test and Xpert MTB/RIF assay for diagnosis of renal tuberculosis.
   Eur J Clin Microbiol Infect Dis. 2020 Sep 29. pii: 10.1007/s10096-020-04052.
   PubMed     Abstract available
   
   
   
7. PHAM TT, Schrenzel J, Janssens JP, Emonet S, et al
   Performances and usefulness of Xpert MTB/RIF assay in low-incidence settings: not that bad?
   Eur J Clin Microbiol Infect Dis. 2020;39:1645-1649.
   PubMed     Abstract available
   
   
   August 2020
8. KAMALI KAKHKI R, Najafzadeh MJ, Kachuei R, Ghazvini K, et al
   Targeting novel genes for simultaneous detection of five fungal and bacterial agents from BAL samples using multiplex PCR assay.
   Eur J Clin Microbiol Infect Dis. 2020;39:1535-1542.
   PubMed     Abstract available
   
   
   July 2020
9. CIESIELCZUK H, Kouvas N, North N, Buchanan R, et al
   Evaluation of the BD MAX MDR-TB assay in a real-world setting for the diagnosis of pulmonary and extra-pulmonary TB.
   Eur J Clin Microbiol Infect Dis. 2020;39:1321-1327.
   PubMed     Abstract available
   
   
   June 2020
10. FAN J, An J, Shu W, Huo F, et al
    Epidemiology of skeletal tuberculosis in Beijing, China: a 10-year retrospective analysis of data.
    Eur J Clin Microbiol Infect Dis. 2020 Jun 19. pii: 10.1007/s10096-020-03924.
    PubMed     Abstract available
    
    
    
11. MA Z, Ji X, Yang H, He J, et al
    Screening and evaluation of Mycobacterium tuberculosis diagnostic antigens.
    Eur J Clin Microbiol Infect Dis. 2020 Jun 16. pii: 10.1007/s10096-020-03951.
    PubMed     Abstract available
    
    
    April 2020
12. SFAIROPOULOS D, Tsiara S, Barkas F, Margariti PN, et al
    Is brucellosis a great mimic of tuberculosis? A case report.
    Eur J Clin Microbiol Infect Dis. 2020 Apr 24. pii: 10.1007/s10096-020-03902.
    PubMed     Abstract available
    
    
    March 2020
13. MENICHINI M, Lari N, Lupetti A, Rindi L, et al
    Evaluation of Xpert MTB/RIF Ultra assay for rapid diagnosis of pulmonary and extra-pulmonary tuberculosis in an Italian center.
    Eur J Clin Microbiol Infect Dis. 2020 Mar 31. pii: 10.1007/s10096-020-03867.
    PubMed    
    
    
    February 2020
14. UZORKA JW, Duinkerk DL, Kroft LJM, Bakker JA, et al
    Trends in diagnostic methods and treatment of latent tuberculosis infection in a tertiary care center from 2000 to 2017.
    Eur J Clin Microbiol Infect Dis. 2020 Feb 20. pii: 10.1007/s10096-020-03850.
    PubMed     Abstract available
    
    
    
15. LI J, Zhao A, Tang J, Wang G, et al
    Tuberculosis vaccine development: from classic to clinical candidates.
    Eur J Clin Microbiol Infect Dis. 2020 Feb 15. pii: 10.1007/s10096-020-03843.
    PubMed     Abstract available
    
    
    January 2020
16. SEMINARI E, Monzillo V, Lombardi A, Barbarini D, et al
    Migrations do not modify Mycobacterium tuberculosis resistance rates: a 20-year retrospective study.
    Eur J Clin Microbiol Infect Dis. 2020 Jan 24. pii: 10.1007/s10096-020-03820.
    PubMed     Abstract available
    
    
    
17. LOPEZ-ROA P, Aznar E, Cacho J, Cogollos-Agruna R, et al
    Epidemiology of Non-Tuberculous Mycobacteria isolated from clinical specimens in Madrid, Spain, from 2013 to 2017.
    Eur J Clin Microbiol Infect Dis. 2020 Jan 24. pii: 10.1007/s10096-020-03826.
    PubMed     Abstract available
    
    
    
18. DU J, Shu W, Liu Y, Wang Y, et al
    Multicenter feasibility study to assess external quality panels for molecular diagnostics for tuberculosis in China.
    Eur J Clin Microbiol Infect Dis. 2020 Jan 3. pii: 10.1007/s10096-019-03730.
    PubMed     Abstract available
    
    
    
19. SHU W, Du J, Liu Y, Wang Y, et al
    External quality control of phenotypic drug susceptibility testing for Mycobacterium tuberculosis in China.
    Eur J Clin Microbiol Infect Dis. 2020 Jan 2. pii: 10.1007/s10096-019-03770.
    PubMed     Abstract available
    
    
    December 2019
20. WEIGL JAI
    Open flanks in the management of tuberculosis in Germany under the pressure of migration.
    Eur J Clin Microbiol Infect Dis. 2019 Dec 17. pii: 10.1007/s10096-019-03791.
    PubMed     Abstract available
    
    
    
21. KWIZERA R, Katende A, Teu A, Apolot D, et al
    Algorithm-aided diagnosis of chronic pulmonary aspergillosis in low- and middle-income countries by use of a lateral flow device.
    Eur J Clin Microbiol Infect Dis. 2019 Dec 6. pii: 10.1007/s10096-019-03782.
    PubMed    
    
    
    
22. DU J, Zhang L, Ma Y, Chen XY, et al
    Treatment and recurrence on re-treatment tuberculosis patients: a randomized clinical trial and 7-year perspective cohort study in China.
    Eur J Clin Microbiol Infect Dis. 2019 Dec 5. pii: 10.1007/s10096-019-03696.
    PubMed     Abstract available
    
    
    
23. SENTIS A, Vasconcelos P, Machado RS, Cayla JA, et al
    Failure to complete treatment for latent tuberculosis infection in Portugal, 2013-2017: geographic-, sociodemographic-, and medical-associated factors.
    Eur J Clin Microbiol Infect Dis. 2019 Dec 3. pii: 10.1007/s10096-019-03765.
    PubMed     Abstract available
    
    
    November 2019
24. CHEN G, Wang H, Wang Y
    Clinical application of QuantiFERON-TB Gold in-tube in the diagnosis and treatment of tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2019 Nov 30. pii: 10.1007/s10096-019-03768.
    PubMed     Abstract available
    
    
    
25. TANOGLU A, Erdem H, Friedland JS, Almajid FM, et al
    Clinicopathological profile of gastrointestinal tuberculosis: a multinational ID-IRI study.
    Eur J Clin Microbiol Infect Dis. 2019 Nov 22. pii: 10.1007/s10096-019-03749.
    PubMed     Abstract available
    
    
    October 2019
26. KONTSEVAYA I, Werngren J, Holicka Y, Klaos K, et al
    Non-commercial phenotypic assays for the detection of Mycobacterium tuberculosis drug resistance: a systematic review.
    Eur J Clin Microbiol Infect Dis. 2019 Oct 30. pii: 10.1007/s10096-019-03723.
    PubMed     Abstract available
    
    
    
27. SAAD J, Loukil A, Drancourt M
    Bead-captured Mycobacterium tuberculosis for next-generation sequencing diagnosis of uncultured tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2019 Oct 14. pii: 10.1007/s10096-019-03700.
    PubMed    
    
    
    August 2019
28. GARCIA-RODRIGUEZ JF, Valcarce-Pardeiro N, Alvarez-Diaz H, Marino-Callejo A, et al
    Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2019 Aug 3. pii: 10.1007/s10096-019-03651.
    PubMed     Abstract available
    
    
    July 2019
29. DU J, Shu W, Liu Y, Wang Y, et al
    Development and validation of external quality assessment panels for mycobacterial culture testing to diagnose tuberculosis in China.
    Eur J Clin Microbiol Infect Dis. 2019 Jul 24. pii: 10.1007/s10096-019-03634.
    PubMed     Abstract available
    
    
    April 2019
30. WEN S, Jing W, Zhang T, Zong Z, et al
    Comparison of in vitro activity of the nitroimidazoles delamanid and pretomanid against multidrug-resistant and extensively drug-resistant tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2019 Apr 5. pii: 10.1007/s10096-019-03551.
    PubMed     Abstract available
    
    
    February 2019
31. MA Y, Che NY, Liu YH, Shu W, et al
    The joint impact of smoking plus alcohol drinking on treatment of pulmonary tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2019 Feb 15. pii: 10.1007/s10096-019-03489.
    PubMed     Abstract available
    
    
    January 2019
32. HODILLE E, Maisson A, Charlet L, Bauduin C, et al
    Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre.
    Eur J Clin Microbiol Infect Dis. 2019 Jan 24. pii: 10.1007/s10096-018-03463.
    PubMed     Abstract available
    
    
    July 2018
33. CENCI E, Luciano E, Bucaioni M, Rubeca M, et al
    Evaluation of IVD 3.0 Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Mycobacterium tuberculosis and nontuberculous mycobacteria and its use in routine diagnostics.
    Eur J Clin Microbiol Infect Dis. 2018 Jul 14. pii: 10.1007/s10096-018-3326.
    PubMed    
    
    
    May 2018
34. ORIKIRIZA P, Nansumba M, Nyehangane D, Bastard M, et al
    Xpert MTB/RIF diagnosis of childhood tuberculosis from sputum and stool samples in a high TB-HIV-prevalent setting.
    Eur J Clin Microbiol Infect Dis. 2018 May 8. pii: 10.1007/s10096-018-3272.
    PubMed     Abstract available
    
    
    April 2018
35. MA Y, Pang Y, Shu W, Liu YH, et al
    Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: experiences from 3-year follow-up.
    Eur J Clin Microbiol Infect Dis. 2018 Apr 20. pii: 10.1007/s10096-018-3242.
    PubMed     Abstract available
    
    
    
36. BRODA A, Nikolayevskyy V, Casali N, Khan H, et al
    Experimental platform utilising melting curve technology for detection of mutations in Mycobacterium tuberculosis isolates.
    Eur J Clin Microbiol Infect Dis. 2018 Apr 20. pii: 10.1007/s10096-018-3246.
    PubMed     Abstract available
    
    
    
37. SEKI M, Kim CK, Hayakawa S, Mitarai S, et al
    Recent advances in tuberculosis diagnostics in resource-limited settings.
    Eur J Clin Microbiol Infect Dis. 2018 Apr 19. pii: 10.1007/s10096-018-3258.
    PubMed     Abstract available
    
    
    
38. DE GEYTER D, Cnudde D, Van der Beken M, Autaers D, et al
    Evaluation of the Copan Myco-TB kit for the decontamination of respiratory samples for the detection of Mycobacteria.
    Eur J Clin Microbiol Infect Dis. 2018;37:711-714.
    PubMed     Abstract available
    
    
    November 2017
39. LACHMANDAS E, Thiem K, van den Heuvel C, Hijmans A, et al
    Patients with type 1 diabetes mellitus have impaired IL-1beta production in response to Mycobacterium tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2017 Nov 30. pii: 10.1007/s10096-017-3145.
    PubMed     Abstract available
    
    
    August 2017
40. LIN HC, Perng CL, Lai YW, Lin FG, et al
    Molecular screening of multidrug-resistance tuberculosis by a designated public health laboratory in Taiwan.
    Eur J Clin Microbiol Infect Dis. 2017 Aug 24. doi: 10.1007/s10096-017-3082.
    PubMed     Abstract available
    
    
    
41. NASIRI MJ, Zamani S, Pormohammad A, Feizabadi MM, et al
    The reliability of rifampicin resistance as a proxy for multidrug-resistant tuberculosis: a systematic review of studies from Iran.
    Eur J Clin Microbiol Infect Dis. 2017 Aug 19. doi: 10.1007/s10096-017-3079.
    PubMed     Abstract available
    
    
    July 2017
42. NAMBIAR R, Chatellier S, Bereksi N, van Belkum A, et al
    Evaluation of Mycotube, a modified version of Lowenstein-Jensen (LJ) medium, for efficient recovery of Mycobacterium tuberculosis (MTB).
    Eur J Clin Microbiol Infect Dis. 2017 Jul 6. doi: 10.1007/s10096-017-3052.
    PubMed     Abstract available
    
    
    June 2017
43. HONG MS, Kim Y, Cho EJ, Lee JS, et al
    Comparison of the characteristics of Mycobacterium tuberculosis isolates from sputum and lung lesions in chronic tuberculosis patients.
    Eur J Clin Microbiol Infect Dis. 2017 Jun 15. doi: 10.1007/s10096-017-3025.
    PubMed     Abstract available
    
    
    
44. MNYAMBWA NP, Kim DJ, Ngadaya ES, Kazwala R, et al
    Clinical implication of novel drug resistance-conferring mutations in resistant tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2017 Jun 7. doi: 10.1007/s10096-017-3027.
    PubMed     Abstract available
    
    
    April 2017
45. WEN HL, Li CL, Li G, Lu YH, et al
    Involvement of methylated HBHA expressed from Mycobacterium smegmatis in an IFN-gamma release assay to aid discrimination between latent infection and active tuberculosis in BCG-vaccinated populations.
    Eur J Clin Microbiol Infect Dis. 2017 Apr 20. doi: 10.1007/s10096-017-2948.
    PubMed     Abstract available
    
    
    December 2016
46. TAN Y, Su B, Zheng H, Wang Y, et al
    Prothionamide susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTECMGIT 960 system.
    Eur J Clin Microbiol Infect Dis. 2016 Dec 20. doi: 10.1007/s10096-016-2859.
    PubMed     Abstract available
    
    
    September 2016
47. KULLIN B, Wojno J, Abratt V, Reid SJ, et al
    Toxin A-negative toxin B-positive ribotype 017 Clostridium difficile is the dominant strain type in patients with diarrhoea attending tuberculosis hospitals in Cape Town, South Africa.
    Eur J Clin Microbiol Infect Dis. 2016.
    PubMed     Abstract available
    
    
    April 2016
48. SINGH VK, Srivastava R, Srivastava BS
    Manipulation of BCG vaccine: a double-edged sword.
    Eur J Clin Microbiol Infect Dis. 2016;35:535-43.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: